A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
Azienda Ospedaliero-Universitaria di Parma
University of Miami
Dartmouth-Hitchcock Medical Center
Azienda Ospedaliero-Universitaria di Parma
City of Hope Medical Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Weill Medical College of Cornell University
Asan Medical Center
University of Nebraska
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Thomas Jefferson University
Advice Pharma Group srl
Pfizer
Tampere University Hospital
OHSU Knight Cancer Institute
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
City of Hope Medical Center
Washington University School of Medicine
University of Nebraska
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Incyte Corporation
University of Virginia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Liege
OHSU Knight Cancer Institute
Notable Labs
Hospices Civils de Lyon
Incyte Corporation
Medigene AG
Rutgers, The State University of New Jersey
Northwestern University
University of Liege
National Cancer Institute (NCI)
Kiadis Pharma